Last Week’s Top Ten: Solvay Gets Ready for Buyout, Amgen Swings Axe, BiPar and that Dude from Dirty Dancing
April 19, 2009 at 4:23 pm EST | Tags: The Top Ten
Though our top post (yeah, you guessed it) continues to be the reigning champ for weeks now, this week’s list has some surprises. So, let’s get to it. Here’s last week’s most viewed posts – The Top Ten – the stories that made us all laugh, cry, gasp and in some cases, lose our tempers…
10 – Layoff Rumors: GSK, Zymogenetics
9 – Uh-Oh, Patient on Novartis’ MS Drug FTY720 Gets Hemorrhaging Focal Encephalitis
8 – Sanofi “Buys” BiPar for $500M…Sanofi Crazy, BiPar Lucky?
7 – Dendreon Data To Be Released Tomorrow at 9AM EST!
6 – Employees Get Boot: J&J, Amgen, Cleveland BioLabs
5 – Cell Therapeutics: Not Down, Not Out…
4 – Cell Therapeutics, Pixantrone – Status?
3 – Pixantrone: Cardiac Issues Yes or No?
1 – Did Vatalanib Work for Patrick Swayze?
See you guys tomorrow bright and early!!!
Image from celebritysmackblog
![[Loading...]](http://www.iguanabio.com/wp-content/themes/IguanaBio/images/ajax-loader.gif){kind=small}
